Clinical Trial Update: Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rituximab for good prognosis microscopic polyangiitis is reported with efficacy and safety data being collected, status is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microscopic Polyangiitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Microscopic Polyangiitis (MPA) | Phase 3 | Status: UNKNOWN